Dashboard
Manage Tickers

BHVN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

this-protagonist-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Protagonist Therapeutics Analyst Begi...
09/17/2025 12:15:15

citigroup-initiates-coverage-on-biohaven-with-buy-rating-announces-price-target-of-28
Citigroup Initiates Coverage On Biohaven w...
09/17/2025 11:30:06

Citigroup analyst Samantha Semenkow initiates coverage on Biohaven (NYSE:BHVN) with a Buy rating and announces Price Target ...

ubs-maintains-buy-on-biohaven-lowers-price-target-to-26
UBS Maintains Buy on Biohaven, Lowers Pric...
09/16/2025 12:43:46

UBS analyst Ashwani Verma maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $27 to $26.

raymond-james-initiates-coverage-on-biohaven-with-strong-buy-rating-announces-price-target-of-75
Raymond James Initiates Coverage On Biohav...
09/03/2025 16:44:36

Raymond James analyst Chris Raymond initiates coverage on Biohaven (NYSE:BHVN) with a Strong Buy rating and announces Price ...

biohaven-advances-toward-potential-first-fda-approved-therapy-for-spinocerebellar-ataxia-fda-drops-advisory-meeting
Biohaven Advances Toward Potential First F...
08/22/2025 13:14:12

Biohaven shares rise as FDA removes advisory committee meeting for troriluzole in spinocerebellar ataxia, with decision expecte...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/22/2025 12:08:33

fda-review-of-biohavens-troriluzole-nda-moves-forward-without-advisory-committee-meeting-decision-targeted-for-late-2025
FDA Review Of Biohaven's Troriluzole NDA M...
08/22/2025 11:06:24

btig-maintains-buy-on-biohaven-raises-price-target-to-60
BTIG Maintains Buy on Biohaven, Raises Pri...
08/19/2025 14:12:48

BTIG analyst Thomas Shrader maintains Biohaven (NYSE:BHVN) with a Buy and raises the price target from $59 to $60.

biohaven-files-prospectus-related-to-register-resale-of-up-to-36m-common-shares-issued-to-selling-shareholder
Biohaven Files Prospectus Related To Regis...
08/15/2025 21:44:18

-SEC Filing

leerink-partners-maintains-outperform-on-biohaven-lowers-price-target-to-50
Leerink Partners Maintains Outperform on B...
08/12/2025 22:03:13

Leerink Partners analyst Marc Goodman maintains Biohaven (NYSE:BHVN) with a Outperform and lowers the price target from $60 ...

morgan-stanley-maintains-overweight-on-biohaven-lowers-price-target-to-54
Morgan Stanley Maintains Overweight on Bio...
08/12/2025 12:22:22

Morgan Stanley analyst Terence Flynn maintains Biohaven (NYSE:BHVN) with a Overweight and lowers the price target from $63 t...

b-of-a-securities-maintains-buy-on-biohaven-lowers-price-target-to-49
B of A Securities Maintains Buy on Biohave...
08/12/2025 11:47:09

B of A Securities analyst Jason Gerberry maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $50 to $49.

baird-maintains-outperform-on-biohaven-lowers-price-target-to-52
Baird Maintains Outperform on Biohaven, Lo...
08/12/2025 11:38:47

Baird analyst Brian Skorney maintains Biohaven (NYSE:BHVN) with a Outperform and lowers the price target from $57 to $52.

hc-wainwright--co-maintains-buy-on-biohaven-lowers-price-target-to-30
HC Wainwright & Co. Maintains Buy on Bioha...
08/12/2025 11:25:20

HC Wainwright & Co. analyst Douglas Tsao maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $54 ...

biohaven-q2-adj-eps-163-beats-172-estimate-cash-4082m
Biohaven Q2 Adj. EPS $(1.63) Beats $(1.72)...
08/11/2025 11:10:58

Biohaven (NYSE:BHVN) reported quarterly losses of $(1.63) per share which beat the analyst consensus estimate of $(1.72) by 5.2...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/30/2025 17:07:24

teradyne-littelfuse-marvell-technology-cheesecake-factory-and-other-big-stocks-moving-higher-on-wednesday
Teradyne, Littelfuse, Marvell Technology, ...
07/30/2025 14:47:26

jp-morgan-maintains-overweight-on-biohaven-lowers-price-target-to-55
JP Morgan Maintains Overweight on Biohaven...
06/18/2025 12:33:07

JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and lowers the price target from $68 to $55.

bexorg-announces-multi-program-research-collaboration-with-biohaven-to-identify-de-risk-and-advance-next-generation-therapies-for-cns-disorders
Bexorg Announces Multi-Program Research Co...
06/10/2025 18:01:39

Bexorg, Inc., a pioneering techbio company working to decode the human brain and advance new therapies for central nervous syst...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION